Glofitamab

Definition: Glofitamab, sold under the brand name Columvi, is a bispecific monoclonal antibody used for the treatment of large B-cell lymphoma. It is a bispecific CD20-directed CD3 T-cell engager developed by Roche. source: Wikipedia

ID

1363208001

ID date

6 Oct 2025

Previous ID

42237911000001103

Name

Glofitamab